Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Scientific nabs French coverage

This article was originally published in The Gray Sheet

Executive Summary

The French government will pay for Taxus Liberté after the drug-eluting stent received reimbursement approval on Feb. 15. The firm notes that the paclitaxel-eluting stent will now be available to patients at both private and public hospitals in France. The device was CE marked in September 2005. According to the firm, France was slow to adopt and reimburse the original Taxus stent (1"The Gray Sheet" Feb. 9, 2004, p. 20)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT023229

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel